Active transport of the angiotensin-II antagonist losartan and its main metabolite EXP 3174 across MDCK-MDR1 and caco-2 cell monolayers.
about
Influence of intermittent hypoxia on myocardial and hepatic P-glycoprotein expression in a rodent modelClinical Implications of P-Glycoprotein Modulation in Drug-Drug Interactions.Tachycardia-induced heart failure does not alter myocardial P-glycoprotein expression.Pharmacokinetic interaction between losartan and Rhodiola rosea in rabbits.Provisional in-silico biopharmaceutics classification (BCS) to guide oral drug product development.Functional interactions between P-glycoprotein and CYP3A in drug metabolism.Sucralose, a synthetic organochlorine sweetener: overview of biological issuesABC of oral bioavailability: transporters as gatekeepers in the gut.Effects of resveratrol on P-glycoprotein and cytochrome P450 3A in vitro and on pharmacokinetics of oral saquinavir in rats.The effects of flavonoids on the ABC transporters: consequences for the pharmacokinetics of substrate drugs.Renal Drug Transporters and Drug Interactions.Screening candidate anticancer drugs for brain tumor chemotherapy: pharmacokinetic-driven approach for a series of (E)-N-(substituted aryl)-3-(substituted phenyl)propenamide analogues.Permeation of losartan across human respiratory epithelium: an in vitro study with Calu-3 cells.Frog intestinal perfusion to evaluate drug permeability: application to p-gp and cyp3a4 substrates.Transport of gemifloxacin, a 4th generation quinolone antibiotic, in the Caco-2 and engineered MDCKII cells, and potential involvement of efflux transporters in the intestinal absorption of the drug.Resolution of P-glycoprotein and non-P-glycoprotein effects on drug permeability using intestinal tissues from mdr1a (-/-) mice.Drug absorption from the isolated perfused rat lung--correlations with drug physicochemical properties and epithelial permeability.Effects of the CYP2C9*13 allele on the pharmacokinetics of losartan in healthy male subjects.Effect of commercial Rhodiola rosea on CYP enzyme activity in humans.Neuroprotective effects of AT1 receptor antagonists after experimental ischemic stroke: what is important?Effect of dietary fibers on losartan uptake and transport in Caco-2 cells.
P2860
Q28576207-DD7F720B-F643-475C-AD51-7F3FFAD8616CQ30234940-1789EB0D-8F71-4729-BA36-4B099E724DCFQ33197068-15609C87-D423-4259-977F-47C4F4F8261BQ34035121-1D97A7E2-6B5B-487C-897A-64E1F904A2DCQ34273688-0C83B097-7121-4F07-AE0E-422B1AE68D64Q34550483-006ECC3C-C987-4120-AD41-F2430A53B333Q34657381-A4F9DF8D-72BE-409D-8821-F9D3C1868B7EQ35591517-182AFAED-5310-4DE2-A0B3-45FBD4E78470Q37426961-92C37537-0C06-4598-A12F-33085BA77235Q38071690-4665F862-8F74-4970-AC8B-8BB76462C7DEQ39140289-3AD00E65-715E-43E8-87B4-DDCDC1711F21Q39387222-CA68C5BF-6B1F-4DCD-BF08-7D8070B03DCEQ39773667-CE52D366-95F7-41B7-8DE3-BFE0EE76D415Q40667203-A85F546C-77CE-4570-AB70-2F3E1A40D74EQ42513426-B5AC53FE-3869-4F3D-831A-C90212711A02Q43263789-A318F3FD-DA24-462C-A2E1-1E44C8297AACQ44507599-960481C0-20CC-4F65-9867-1F97ACB3EED9Q45928715-87B80555-7B8E-45A8-B969-ACFF16BD7C6DQ47622129-8B61715E-15A8-48B4-8D34-7E7DCC9DA61FQ48189466-342F91C4-8483-4E89-BBD5-1E6CCBA5C18EQ53642893-8969294D-C59A-422B-B5BA-BBF2E0CB51B8
P2860
Active transport of the angiotensin-II antagonist losartan and its main metabolite EXP 3174 across MDCK-MDR1 and caco-2 cell monolayers.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Active transport of the angiot ...... R1 and caco-2 cell monolayers.
@en
type
label
Active transport of the angiot ...... R1 and caco-2 cell monolayers.
@en
prefLabel
Active transport of the angiot ...... R1 and caco-2 cell monolayers.
@en
P2093
P2860
P356
P1476
Active transport of the angiot ...... R1 and caco-2 cell monolayers.
@en
P2093
E Mutschler
U Christians
P2860
P304
P356
10.1038/SJ.BJP.0703150
P407
P577
2000-03-01T00:00:00Z